Paliperidone Krka

Paliperidone, the active ingredient in Paliperidone Krka, is an atypical antipsychotic presented as a strength/form for oral use. It treats schizophrenia and schizoaffective disorder in adult patients. GNH USA supplies Paliperidone Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Paliperidone Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidone is an atypical antipsychotic that modulates dopamine pathways in psychotic disorders. - Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Schizoaffective disorder: Improves mood symptoms and psychotic features. - Maintenance therapy: Supports long‑term stability after an acute episode.

Paliperidone may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Insomnia: difficulty falling or staying asleep. - Restlessness (akathisia): feeling of inner restlessness. - Weight gain: gradual increase in body weight. - Dry mouth: reduced salivation. - Constipation: decreased bowel movements.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: potentially life‑threatening reaction. - Tardive dyskinesia: persistent involuntary movements. - Seizures: increased risk in susceptible individuals. - Orthostatic hypotension: sudden drop in blood pressure on standing. - Hyperglycaemia: elevated blood glucose levels. - Elevated prolactin: galactorrhoea or menstrual disturbances.

When prescribing Paliperidone, clinicians should evaluate patient history and monitor for specific risks. - Cardiovascular assessment: check for QT prolongation and arrhythmias. - Metabolic monitoring: track weight, glucose, and lipid levels. - Movement disorders: observe for signs of tardive dyskinesia or akathisia. - Pregnancy and lactation: weigh benefits against potential fetal risks. - Elderly patients: use caution due to increased sensitivity to side effects. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Paliperidone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid):\n- Strong CYP3A4 inhibitors: may increase paliperidone exposure. - QT‑prolonging agents: additive risk of cardiac arrhythmias. - CNS depressants: heightened sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance orthostatic hypotension. - Anticholinergic agents: may worsen dry mouth and constipation. - Other antipsychotics: increased risk of extrapyramidal symptoms.